1. Home
  2. EVCM vs VERA Comparison

EVCM vs VERA Comparison

Compare EVCM & VERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo EverCommerce Inc.

EVCM

EverCommerce Inc.

HOLD

Current Price

$12.01

Market Cap

2.1B

Sector

Technology

ML Signal

HOLD

Logo Vera Therapeutics Inc.

VERA

Vera Therapeutics Inc.

HOLD

Current Price

$47.70

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EVCM
VERA
Founded
2006
2016
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
1.5B
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
EVCM
VERA
Price
$12.01
$47.70
Analyst Decision
Hold
Strong Buy
Analyst Count
8
11
Target Price
$11.50
$76.60
AVG Volume (30 Days)
329.1K
1.4M
Earning Date
11-06-2025
02-25-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$718,038,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$5.60
N/A
P/E Ratio
N/A
N/A
Revenue Growth
22.13
N/A
52 Week Low
$7.66
$18.53
52 Week High
$14.41
$56.05

Technical Indicators

Market Signals
Indicator
EVCM
VERA
Relative Strength Index (RSI) 58.38 56.35
Support Level $10.88 $45.50
Resistance Level $12.44 $50.79
Average True Range (ATR) 0.54 2.43
MACD -0.08 -1.17
Stochastic Oscillator 59.90 25.78

Price Performance

Historical Comparison
EVCM
VERA

About EVCM EverCommerce Inc.

EverCommerce Inc provides tailored Software-as-a-Service solutions for service-based small- and medium-sized businesses (SMBs) in-home services, health services, and fitness & wellness. With a platform serving approximately 708,000 customers across three core verticals, including numerous micro-verticals, their solutions address diverse needs within these sectors. Revenue is mostly generated from the United States. Operating in a single segment, their vertically-tailored SaaS offerings cater to SMBs' specialized demands, enabling them to automate processes, generate business, and enhance customer loyalty. The majority of customers contribute modest revenue, with a small percentage contributing higher amounts.

About VERA Vera Therapeutics Inc.

Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.

Share on Social Networks: